Massive 10-Million Patient Study Develops Blood-Based Pan-Cancer Screening Model — Clinical Implications for Early Detection

References

1. 1.Chen, X., Gole, J., Gore, A., He, Q., Lu, M., Min, J., Yuan, Z., Yang, X., Jiang, Y., Zhang, T., Suo, C., Li, X., Cheng, L., Zhang, Z., Zhang, H., Xiao, M., Li, Y., Mu, D., Huang, H., ... Weissleder, R. (2020). Non-invasive early detection of cancer four years before conventional diagnosis using a blood test. Nature Communications, 11(1), 3475. https://doi.org/10.1038/s41467-020-17316-z
2. 2.Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007). Human papillomavirus and cervical cancer. The Lancet, 370(9590), 890-907. https://doi.org/10.1016/S0140-6736(07)61416-0
3. 3.Smith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram‐Baptiste, D., Saslow, D., & Wender, R. C. (2019). Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA: A Cancer Journal for Clinicians, 69(3), 184-210. https://doi.org/10.3322/caac.21557
4. 4.Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209-249. https://doi.org/10.3322/caac.21660
5. 5.Zhejiang Cancer Hospital. (2024). Establishment of a Pan-Cancer Screening Model Based on Blood Biomarkers. ClinicalTrials.gov. NCT07554157. https://clinicaltrials.gov/study/NCT07554157